Sort   by:  
 Page size 
UnknownEffects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial.
Not available
S-EPMC12274867 | biostudies-literature
UnknownAssessing the causal role of epigenetic clocks in the development of multiple cancers: a Mendelian randomization study.
Not available
S-EPMC9049976 | biostudies-literature
UnknownGenetic architectures of proximal and distal colorectal cancer are partly distinct.
Not available
S-EPMC8223655 | biostudies-literature
UnknownMeta-analysis of Parkinson's disease: identification of a novel locus, RIT2.
Not available
S-EPMC3354734 | biostudies-literature
UnknownAssociation between circulating inflammatory markers and adult cancer risk: a Mendelian randomization analysis.
Not available
S-EPMC10844944 | biostudies-literature
UnknownPrevalence and architecture of de novo mutations in developmental disorders.
Not available
S-EPMC6016744 | biostudies-literature
UnknownNot all SCN1A epileptic encephalopathies are Dravet syndrome: Early profound Thr226Met phenotype.
Not available
S-EPMC5589790 | biostudies-literature
UnknownHistone Lysine Methylases and Demethylases in the Landscape of Human Developmental Disorders.
Not available
S-EPMC5778085 | biostudies-literature
UnknownFrailty, Multimorbidity, and Polypharmacy: Exploratory Analyses of the Effects of Empagliflozin from the EMPA-KIDNEY Trial.
Not available
S-EPMC11390031 | biostudies-literature
UnknownLong-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease.
Not available
S-EPMC7616743 | biostudies-literature
Sort   by:  
 Page size